Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Discover the latest advances in canine lymphoma with Avacta Animal Health


Print article Print article

Arno Roos
Arno Roos
2014-04-09 16:25:27 -

Avacta Animal Health invites members of the veterinary profession to join its free webinar hosted by CPD solutions on Canine Lymphoma, Current Perspectives on Diagnosis, Treatment and Monitoring on the 24th of April, when leading veterinarian Arno Roos will present the latest thinking on the diagnosis, treatment and monitoring of the disease. The presentation will include an overview of the pathology of lymphoma, diagnosis, chemotherapeutic regimens, and an introduction to Avacta’s SENSITEST® cLBT (canine lymphoma blood test) and its use for diagnostic and monitoring purposes. The capability of this test to differentiate between dogs in remission and those with recurring disease, as well as its potential to aid monitoring of disease status, was recently demonstrated during a blind, retrospective study

of the remission and recurrence responses of canine lymphoma patients treated by chemotherapy1.

Arno Roos obtained a degree in veterinary medicine from Utrecht University, Netherlands, and then trained in oncology and radiotherapy, establishing his veterinary practice as a referral centre for oncological diseases. In 2013, he completed an MSc in clinical oncology at the University of Birmingham, UK, including a dissertation on the use of serum proteomic profiling in the diagnosis and monitoring of dogs with malignant lymphoma. These results, presented at the Veterinary Cancer Society (VCS) conference in Minneapolis, USA, in October last year, demonstrated the very high sensitivity and specificity of the cLBT for diagnosis, as well as its prognostic importance. Arno is a member of the VCS and the European Society of Veterinary Oncology.

To register for the webinar, visit www.caninelymphoma.co.uk
For more information about SENSITEST cLBT, visit www.avactaanimalhealth.com

1Alexandrakis, I., Tuli, R., Ractliffe, S., Tappin, S., Foale, R., Roos, A., Slater, K. Utility of a multiple serum biomarker test to monitor remission status and relapse in 57 dogs undergoing treatment with chemotherapy. Veterinary and Comparative Oncology. In press.


Contact Information:
kdm Communications ltd

Cressner House,
St Neots
Cambs
PE19 1BG

Contact Person:


email: email




Author:
Sophie Woodward
e-mail
Web: www.kdm-communications.com
Phone: 01480405333

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com